Navigation Links
Maternal malaria researcher wins prestigious international prize
Date:6/11/2008

Groundbreaking research into treating malaria infections in pregnant women has earned Professor Franois Nosten, Director of the Wellcome Trust-funded Shoklo Malaria Research Unit (SMRU) in Mae Sot, Thailand, international recognition. Professor Nosten today receives the Christophe & Rodolphe Merieux Foundation Prize, a 400,000 prize awarded to a researcher or research team studying infectious diseases in developing countries, presented by the Institut de France.

"I'm delighted to have received this award," says Professor Nosten. "The recognition from my home country for the work of myself and my colleagues is very important, and the prize money will allow me to conduct more work on maternal malaria, a poorly-researched area."

Malaria is one of the world's deadliest killers, killing over a million people each year, mainly pregnant women and young children in Africa and south east Asia. Although treatments exist to tackle the disease, which is caused by Plasmodium parasites, until Professor Nosten's work, little was known about how to treat pregnant women, particularly in areas where the parasites have been increasingly developing resistance to treatment.

"Pregnant women are always excluded from clinical trials because of the fear of harming the unborn baby," explains Professor Nosten, a professor at the University of Oxford. "Paradoxically it was considered unethical to recruit pregnant women in studies, but ethical to leave them untreated."

Professor Nosten, together with Professor Nick White, Chairman of the Wellcome Trust's South East Asia Programme, began researching maternal malaria over twenty years ago in 1986 on the border of Thailand and Burma where they saw many pregnant women dying from malaria. By organising antenatal consultations for all pregnant women to screen their blood every week during the pregnancy, they were able to detect malaria parasites quickly and treat them before they developed into severe infection.

"The antenatal screenings were very time intensive, but the system worked beautifully," says Professor Nosten. "The number of pregnant women dying from malaria fell from one death per hundred live births to zero."

The success of their approach enabled the team to focus on the prevention and treatment of malaria in pregnant women, and area where very few studies had previously been conducted. Professor Nosten and colleagues have undertaken most of the clinical trials looking at the best treatment options, including looking at how antimalarials are absorbed and metabolised by the body. This allowed them that pregnancy alters the efficacy of antimalarials and that the doses of medicines given to pregnant women were too low and therefore less efficacious.

Their work has led to a revision of guidelines produced by the World Health Organisation (WHO), which now recommend treating women in the second and third trimesters of pregnancy with artemisinin combination therapies. They have also provided almost all the available clinical evidence on the safety of treating pregnant women with artemisinin therapies, including the largest series on exposure during the first trimester.

Professor White says: " Franois and his team work in very difficult circumstances, yet they have produced some of the most important research on the treatment of malaria, which has led to a global change in treatment recommendations. They have conducted pivotal work on the epidemiology, pathophysiology and treatment of malaria in pregnancy, and changed the way it is treated."

"I would like to congratulate Franois on receiving well deserved recognition for his important achievements," say Dr Mark Walport, Director of the Wellcome Trust. "Malaria is one of the world's major killers and treating pregnant women has often proved complicated and potentially dangerous. Thanks to the work of Francois and his colleagues, however, the treatment options are now much clearer, reducing the risk to the mothers. His work has been invaluable for saving the lives of many women and their unborn children."


'/>"/>

Contact: Craig Brierley
c.brierley@wellcome.ac.uk
44-207-611-7329
Wellcome Trust
Source:Eurekalert

Related medicine news :

1. Stronger Health Systems and Better Maternal Health Critical to African Development, Japan Summit Affirms
2. Few Countries on Track to Curb Maternal, Child Mortality Rates
3. Maternal love: How a mothers brain responds to her infant
4. Prenatal exposure to maternal antibodies linked to autistic behaviors in offspring
5. Maternal Distress Raises Risk of Childhood Asthma
6. November issue of Reproductive Health Matters focuses on maternal mortality
7. A maternal link to Alzheimers disease
8. MacArthur commits $11 million to further UCSF work in maternal safety
9. Maternal Mortality Declining in Middle-income Countries; Women Still Die in Pregnancy and Childbirth in Low-income Countries
10. Lynn Clark Callister, National Leader in Maternal-Child Health Nursing, Joins March of Dimes Advisory Council
11. Maternal depression and controlling behavior associated with increased stress response in infants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... ... May 25, 2016 , ... The Global Wellness Summit (GWS) today announced that ... offerings of Europe, a continent that pioneered the medical/wellness concept for the world. , ... in medical wellness, including Henri Chenot, Founder of the Chenot Group, which operates wellness ...
(Date:5/25/2016)... , ... May 25, 2016 , ... Casa Velas, an ... properties of precious stones to complement its new wellness suites . The two ... and feature a plethora of special services and insuite amenities, from a custom soap ...
(Date:5/25/2016)... ... May 25, 2016 , ... America Walks , a national advocacy ... of the University of Pittsburgh Graduate School of Public Health , has been ... and 24 other advocates from around the country to participate in a four-month training ...
(Date:5/25/2016)... ... 25, 2016 , ... "FCPX LUT Intense allows users to cycle through different ... - CEO of Pixel Film Studios. , With the FCPX LUT Intense ... grades to their footage. A LUT is a Lookup Table that contains a mathematical ...
(Date:5/25/2016)... , ... May 25, 2016 , ... Consumer access to ... early June 2016, Kashi®, a maker of whole grain cereals and other plant-based foods, ... Transitional ingredient: hard red winter wheat processed by Hesco/Dakota Organic Products. , The ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... , May 23, 2016 The World Health Organization ... device to include adolescents aged 13 years, and above. ... be offered for adult and adolescent males in the 14 ... . PrePex was the first male circumcision device to receive ... CEO, Eddy Horowitz said: " The expanded ...
(Date:5/23/2016)... 2016 Gamida Cell, a leader ... cancer and orphan genetic diseases, announced today it has ... from the Israel Innovation Authority (formerly the Office of ... and Industry. The mission of the Israel Innovation Authority ... including science and technology, while stimulating economic growth. ...
(Date:5/22/2016)... , May 23, 2016 ... develop its anti-fibrotic and anti-inflammatory compound DS102 in ... as in non-alcoholic steatohepatitis (NASH) patients. ... significantly sequestered in lung tissue and has bronchodilatory, ... after oral administration. The Company will publish further ...
Breaking Medicine Technology: